# FDA Inspection 1016270 - ASRI-WPAHS IRB - May 23, 2017

Source: https://www.keypedia.com/records/fda_inspections/asri-wpahs-irb/3a02227e-20f5-468b-b5c5-0b5d1deeafb2
Source feed: FDA_Inspections

> FDA Inspection 1016270 for ASRI-WPAHS IRB on May 23, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1016270
- Company Name: ASRI-WPAHS IRB
- Inspection Date: 2017-05-23
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs

## Related Documents

- [FDA Inspection 1016270 - 2017-05-23](https://www.keypedia.com/records/fda_inspections/asri-wpahs-irb/1375ac2e-bfb8-4140-adf1-6167a45640e7)
- [FDA Inspection 798626 - 2012-09-12](https://www.keypedia.com/records/fda_inspections/asri-wpahs-irb/07c3e897-9419-4fc1-8b02-0f797351fc93)
- [FDA Inspection 798626 - 2012-09-12](https://www.keypedia.com/records/fda_inspections/asri-wpahs-irb/7706bc0a-8487-4b2e-9a41-ea8cc02f4828)

Company: https://www.keypedia.com/companies/asri-wpahs-irb/3397e58e-f26e-4d8f-adc1-2e2d20bec9a1